MENU
+Compare
SDZNY
Stock ticker: OTC
AS OF
Apr 17 closing price
Price
$40.24
Change
+$0.14 (+0.35%)
Capitalization
11.43B

SDZNY Sandoz Group AG Forecast, Technical & Fundamental Analysis

Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs... Show more

SDZNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SDZNY with price predictions
Apr 17, 2025

SDZNY's RSI Indicator ascends from oversold territory

The RSI Indicator for SDZNY moved out of oversold territory on April 10, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 8 similar instances when the indicator left oversold territory. In of the 8 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SDZNY just turned positive on April 15, 2025. Looking at past instances where SDZNY's MACD turned positive, the stock continued to rise in of 9 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SDZNY advanced for three days, in of 93 cases, the price rose further within the following month. The odds of a continued upward trend are .

SDZNY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SDZNY as a result. In of 25 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SDZNY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SDZNY entered a downward trend on April 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SDZNY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (61.171). P/E Ratio (0.000) is within average values for comparable stocks, (90.174). SDZNY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (20.123).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SDZNY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SDZNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIRBX70.110.30
+0.43%
American Funds Capital Income Bldr R2
NWHDX13.05N/A
N/A
Nationwide Bailard Cogntv Val A
OSMNX34.41N/A
N/A
Invesco International Small-Mid Com R
ERIFX11.00N/A
N/A
Eaton Vance Balanced R
RTDAX13.52N/A
N/A
Russell Inv Multifactor US Equity A

SDZNY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SDZNY has been loosely correlated with SDZXF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SDZNY jumps, then SDZXF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZNY
1D Price
Change %
SDZNY100%
+0.35%
SDZXF - SDZNY
44%
Loosely correlated
+3.18%
CPHRF - SDZNY
21%
Poorly correlated
+0.35%
TAK - SDZNY
21%
Poorly correlated
+0.41%
AVDL - SDZNY
20%
Poorly correlated
-1.47%
APNHY - SDZNY
20%
Poorly correlated
+1.62%
More

Groups containing SDZNY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SDZNY
1D Price
Change %
SDZNY100%
+0.35%
Pharmaceuticals
category (304 stocks)
21%
Poorly correlated
+1.58%
Pharmaceuticals: Other
category (212 stocks)
13%
Poorly correlated
+1.51%